Skip to main content
logo
Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.7990
+0.0160 (2.04%)
At close: Feb 13, 2026, 4:00 PM EST
0.7760
-0.0230 (-2.88%)
After-hours: Feb 13, 2026, 6:16 PM EST

Cellyan Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23
Market Capitalization
912--
Enterprise Value
814--
Last Close Price
0.801.08--
PS Ratio
0.400.59--
PB Ratio
1.762.38--
P/TBV Ratio
1.802.43--
P/FCF Ratio
17.6023.79--
P/OCF Ratio
15.4420.87--
EV/Sales Ratio
0.400.68--
EV/EBITDA Ratio
30.6752.12--
EV/EBIT Ratio
42.8872.87--
EV/FCF Ratio
16.3427.77--
Debt / Equity Ratio
0.480.480.491.18
Debt / EBITDA Ratio
1.881.880.800.41
Debt / FCF Ratio
4.764.76-0.43
Net Debt / Equity Ratio
-0.13-0.130.350.28
Net Debt / EBITDA Ratio
-2.37-2.370.850.16
Net Debt / FCF Ratio
-1.26-1.26-3.280.10
Asset Turnover
2.252.252.76-
Inventory Turnover
23.9723.9723.36-
Quick Ratio
2.652.651.370.88
Current Ratio
2.992.992.461.08
Return on Equity (ROE)
-0.58%-0.58%54.96%-
Return on Assets (ROA)
1.31%1.31%17.28%-
Return on Invested Capital (ROIC)
-3.27%-2.83%44.93%127.37%
Return on Capital Employed (ROCE)
2.90%2.90%30.40%114.30%
Earnings Yield
-0.31%-0.23%--
FCF Yield
5.68%4.20%--
Buyback Yield / Dilution
-38.56%-38.56%-7.64%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q